Literature DB >> 7495307

Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.

L L Muldoon1, G Nilaver, R A Kroll, M A Pagel, X O Breakefield, E A Chiocca, B L Davidson, R Weissleder, E A Neuwelt.   

Abstract

Delivery of adenovirus, herpes simplex virus (HSV), and paramagnetic monocrystalline iron oxide nanoparticles (MION) to rat brain (n = 64) was assessed after intracerebral inoculation or osmotic disruption of the blood-brain barrier (BBB). After intracerebral inoculation, the area of distribution was 7.93 +/- 0.43 mm2 (n = 9) for MION and 9.17 +/- 1.27 mm2 (n = 9) for replication-defective adenovirus. The replication-compromised HSV RH105 spread to 14.00 +/- 0.87 mm2 (n = 8), but also had a large necrotic center (3.54 +/- 0.47 mm2). No infection was detected when virus was administered intra-arterially without hyperosmotic mannitol. After osmotic BBB disruption, delivery of the viruses and MIONs was detected throughout the disrupted cerebral cortex. Positive staining was found in 4 to 845 cells/100 microns thick coronal brain section (n = 7) after adenovirus administration, and in 13 to 197 cells/section (n = 8) after HSV administration. Cells of glial morphology were more frequently stained after administration of adenovirus, whereas neuronal cells were preferentially stained after delivery of both HSV vectors and MION. In a preliminary test of vector delivery in the feline, MION was detected throughout the white matter tracts after inoculation into normal cat brain. Thus MION may be a tool for use in vivo, to monitor the delivery of virus to the central nervous system. Additionally, BBB disruption may be an effective method to globally deliver recombinant viruses to the CNS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495307      PMCID: PMC1869962     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.

Authors:  D M Coen; D J Goldstein; S K Weller
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Experimental superficial siderosis of the central nervous system. I. Morphological observations.

Authors:  A H Koeppen; R C Borke
Journal:  J Neuropathol Exp Neurol       Date:  1991-09       Impact factor: 3.685

3.  Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier.

Authors:  E A Neuwelt; M A Pagel; R D Dix
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

4.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.

Authors:  R Weissleder; G Elizondo; J Wittenberg; A S Lee; L Josephson; T J Brady
Journal:  Radiology       Date:  1990-05       Impact factor: 11.105

5.  Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier.

Authors:  S I Rapoport; P J Robinson
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

6.  Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants.

Authors:  E A Chiocca; B B Choi; W Z Cai; N A DeLuca; P A Schaffer; M DiFiglia; X O Breakefield; R L Martuza
Journal:  New Biol       Date:  1990-08

7.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

Authors:  D M Coen; M Kosz-Vnenchak; J G Jacobson; D A Leib; C L Bogard; P A Schaffer; K L Tyler; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

Authors:  E A Neuwelt; D L Goldman; S A Dahlborg; J Crossen; F Ramsey; S Roman-Goldstein; R Braziel; B Dana
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

9.  Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study.

Authors:  Q Huang; J P Vonsattel; P A Schaffer; R L Martuza; X O Breakefield; M DiFiglia
Journal:  Exp Neurol       Date:  1992-03       Impact factor: 5.330

10.  Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

Authors:  G Nilaver; L L Muldoon; R A Kroll; M A Pagel; X O Breakefield; B L Davidson; E A Neuwelt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

View more
  24 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 3.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

4.  Intracellular gene transcription factor protein-guided MRI by DNA aptamers in vivo.

Authors:  Christina H Liu; Jiaqian Ren; Charng-Ming Liu; Philip K Liu
Journal:  FASEB J       Date:  2013-10-10       Impact factor: 5.191

5.  Noninvasive detection of neural progenitor cells in living brains by MRI.

Authors:  Christina H Liu; Jia Q Ren; Zerong You; Jinsheng Yang; Charng-Ming Liu; Ritika Uppal; Philip K Liu
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

6.  Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain Barrier.

Authors:  Bruno M D C Godinho; Nils Henninger; James Bouley; Julia F Alterman; Reka A Haraszti; James W Gilbert; Ellen Sapp; Andrew H Coles; Annabelle Biscans; Mehran Nikan; Dimas Echeverria; Marian DiFiglia; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther       Date:  2018-08-08       Impact factor: 11.454

7.  Endocytic uptake pathways utilized by CPMV nanoparticles.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Mol Pharm       Date:  2012-09-20       Impact factor: 4.939

8.  MRI reveals differential effects of amphetamine exposure on neuroglia in vivo.

Authors:  Christina H Liu; Jinsheng Yang; Jia Q Ren; Charng-Ming Liu; Zerong You; Philip K Liu
Journal:  FASEB J       Date:  2012-11-12       Impact factor: 5.191

9.  Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.

Authors:  Leah P Shriver; Kristopher J Koudelka; Marianne Manchester
Journal:  J Neuroimmunol       Date:  2009-04-25       Impact factor: 3.478

Review 10.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.